Cicas IP v. Intuitive Surgical: Endoscopic Patent Case Ends in Dismissal
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Cicas IP, LLC v. Intuitive Surgical, Inc. et al. |
| Case Number | 2:23-cv-00294 (E.D. Tex.) |
| Court | U.S. District Court for the Eastern District of Texas |
| Duration | June 22, 2023 – March 21, 2024 273 days |
| Outcome | Dismissed with Prejudice |
| Patents at Issue | |
| Accused Products | da Vinci Surgical System |
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity (PAE) focused on acquiring and licensing intellectual property, asserting rights in endoscopic imaging and targeting technology.
🛡️ Defendant
The global operating enterprise behind the da Vinci Surgical System, the world’s leading robotic-assisted surgical platform. Includes six international entities.
The Patent at Issue
This case involved **U.S. Patent No. 6,850,794 B2** (Application No. 09/957,477), covering an *endoscopic targeting method and system* — technology directed at guiding and positioning endoscopic instruments during minimally invasive surgical procedures. The patent sits squarely within the foundational technology layer underlying robotic and computer-assisted surgical navigation.
- • US 6,850,794 B2 — Endoscopic targeting method and system
Developing surgical robotics technology?
Check if your endoscopic design might infringe this or related patents before launch.
The Verdict & Legal Analysis
Outcome
On **March 21, 2024**, the Eastern District of Texas accepted the parties’ **Joint Stipulation of Dismissal with Prejudice** (Dkt. No. 89), formally closing Case No. 2:23-cv-00294. The court’s order (Dkt. No. 90) confirmed that all claims and causes of action between Cicas IP, LLC and all Intuitive Defendants were **dismissed with prejudice**, with **each party bearing its own costs, expenses, and attorneys’ fees**. No damages amount was publicly disclosed.
Verdict Cause Analysis
The underlying cause of action was a standard **patent infringement claim** under 35 U.S.C. § 271. While the court record does not reveal specific claim construction rulings, validity challenges, or infringement findings, the dismissal **with prejudice** coupled with **each party bearing its own fees** is a hallmark signature of a **confidential settlement agreement**. This structure protects both sides, allowing for early resolution without prolonged litigation or adverse rulings.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in surgical robotics. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in the endoscopic targeting space
- See which companies are most active in surgical robotics patents
- Understand patent assertion entity strategies
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Endoscopic targeting & surgical navigation
Active Litigation
In surgical robotics sector
Proactive FTO
Essential for new market entrants
✅ Key Takeaways
Dismissal with prejudice and mutual fee-bearing is a strong indicator of a confidential settlement.
Search related case law →The Eastern District of Texas continues to attract PAE filings; venue strategy remains a critical early decision.
Explore litigation trends →Commission FTO analyses covering endoscopic navigation and targeting patents before product commercialization.
Run FTO analysis for my product →Foundational surgical imaging patents from the early 2000s remain active enforcement tools.
Identify blocking patents →Frequently Asked Questions
U.S. Patent No. 6,850,794 B2 (Application No. 09/957,477), covering an endoscopic targeting method and system, was the sole patent asserted in this case.
The parties filed a Joint Stipulation of Dismissal (Dkt. No. 89), representing that all claims had been resolved. A with-prejudice dismissal with each party bearing its own fees strongly indicates a confidential settlement agreement.
The case confirms that legacy endoscopic and surgical navigation patents remain viable enforcement tools against market leaders. Companies in this space should prioritize FTO clearance and patent landscape monitoring.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- PACER Case Lookup — Case No. 2:23-cv-00294, E.D. Tex.
- USPTO Patent US6850794B2
- U.S. Patent and Trademark Office — Patent Resources
- Cornell Legal Information Institute — 35 U.S.C. § 271
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.